Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dreismann Joins AdvanDx Board; ACMG Names Gail Herman as President

Premium

AdvanDx said this week that Heiner Dreismann has joined the company's board of directors as an independent director.

Dreismann was an executive at the Roche group from 1985 to 2006, where he held several senior positions, including president and CEO of Roche Molecular Systems. He also served as a member of Roche's Global Diagnostic Executive Committee.

Dreismann currently serves on the board of directors of several public and private healthcare and diagnostic companies, including Myriad Genetics. He holds an MS in biology and PhD in microbiology/molecular biology from the University of Münster in Germany.


Gail Herman has been named the new president of the American College of Medical Genetics and Genomics.

Herman takes over from Wayne Grody, who completed his two-year term at the 2013 Annual Clinical Genetics Meeting in Phoenix, Ariz., in March.

Herman holds a degree in chemistry from Smith College and a PhD in biochemistry and MD from Duke University. She completed residency training in pediatrics and a fellowship in genetics at Baylor College of Medicine, where she later joined the faculty in the Institute for Molecular and Human Genetics as an assistant and then associate professor.

She joined the pediatrics department at Nationwide Children's Hospital and Ohio State University in 1997 and was promoted to professor in 2000. There, she served as director of the division and of the Center for Molecular and Human Genetics from 1998 to 2009.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.